RBC Inclusions Decoded: Diagnostic Pearls from William Aird
William Aird, Professor of Medicine at Harvard Medical School, posted on X:
”1/7
RBC INCLUSIONS
Red blood cell (RBC) inclusions: small structures with big diagnostic value. Each one points to a different process, from marrow stress to iron overload to infection. Here’s a tour, one inclusion at a time.
2/7
Nucleated RBCs: immature erythroid precursors that still carry their nucleus.
- Normally confined to the marrow (except neonates).
- In circulation, signal marrow under stress (hemolysis, hypoxia, marrow infiltration)
Think of them as a sign of the BM “pushing hard.”
3/7
Howell–Jolly bodies: small, round basophilic nuclear remnants (DNA) DNA found within circulating RBCs.
- Appear when the spleen is absent or not functioning (asplenia, hyposplenism).
- If you see them, ask about the spleen.
See here.
4/7
Basophilic stippling: numerous fine or coarse punctate, blue-purple granules (aggregates of ribosomal RNA).
- Causes include thalassemia, lead poisoning, sideroblastic anemia.
- Coarse stippling is especially associated with lead.
5/7
Pappenheimer bodies: iron-containing granules (siderotic granules) in RBCs.
- Stain positive with Prussian blue
- Seen in sideroblastic anemia, iron overload, post-splenectomy.
See here.
6/7
Intraerythrocytic parasites: malaria, babesiosis.
- Morphology varies (rings, trophozoites, schizonts, gametocytes).
- Always correlate with travel/exposure history; finding parasites in RBCs is a diagnostic emergency.
7/7
Red cell inclusions provide direct windows into pathophysiology: nuclear remnants, iron deposits, ribosomal aggregates, or pathogens. Recognizing them is a high- yield skill at the microscope.”
Stay updated with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals